Real World Adherence of PCSK9 Targeted Therapy

Clinical trial NCT07468500 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07468500
Sponsor: Novartis Pharmaceuticals
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Dyslipidemia, Hypercholesterolemia

Start date: 2026-03-30
Primary completion: 2026-07-30
Enrollment: 3600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.